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The immune response of inbred strains of mice to the random terpolymer
L-glutamic acids°-L-alanine"-L-tyrosine" (GAT)' is controlled by a specific
autosomal dominant immune response (Ir) gene which maps in the Ir-IA, Ir-IB
regions of the H-2 complex (1-3). In previous reports in this series, we have
described the parameters for development of primary GAT-specific IgG plaque-
forming cell (PFC) responses in mouse spleen cell cultures (4). Spleen cells from
both responder (H-2a,b.d.k) and nonresponder (H-2P. -) mice develop GAT-
specific IgG PFC responses after incubation with GAT complexed to methylated
bovine serum albumin (GAT-MBSA) (4). However, only spleen cells from
responder mice develop a GAT-specific PFC response when incubated with
soluble GAT or macrophage-bound GAT (GAT-MP) (5).
The immune responses to GAT and GAT-MBSA are dependent on the helper influence
of T cells (6). Thus, spleen cells from GAT-primed, irradiated responder mice have
GAT-specific helper T-cell function, while no GAT-specific helper cell function could be
demonstrated in spleen cells from GAT-primed, irradiated nonresponder mice . B cells
from nonresponder mice also differ from the B cells of responder animals in their
susceptibility to suppression in culture by concentrations of soluble GAT, which are
immunogenic for B cells of responder mice (7). In addition, GAT not only fails to elicit a
GAT-specific response in nonresponder mice, but also specifically decreases the ability of
nonresponder mice to develop a GAT-specific PFC response to a subsequent challenge
with thenormally immunogenic GAT-MBSA (7). This unresponsiveness is the result of an
active suppression; spleen cells from GAT-primed nonresponder mice of the H-2-"
haplotypes could specifically suppress the anti-GAT PFC response of syngeneic spleen
*This investigation was supported by U.S. Public Health Service Grants AI-09920 and AI-09897
from the National Institute of Allergy and Infectious Diseases.
$Recipient of U.S. Public Health Service Research Career Development Award 5K04-AI-70173
from the National Institute of Allergy and Infectious Diseases.
'Abbreviations used in this paper: B cell, precursor of antibody-producing cell; C, complement;
GAT, random terpolymer of L-glutamic acids°-L-alanine3°-L-tyrosine'°; GAT-MBSA, GAT com-
plexed to methylated bovine serum albumin; GAT-M4), macrophage-bound GAT; GAT-SRBC, GAT
coupled to sheepred bloodcells; H-2, majorhistocompatibility complex in mice;Ig, Immunoglobulin:
IgG refers to IgG, and IgG,28 + 2b1; Ir gene, specific immune response gene; M4;, macrophage; PFC,
plaque-forming cells; (T,G)-A--L, Poly(L-tyrosine, L-glutamic acid)-POIYDL-alanine-poly-L-lysine;
B, Surfacealloantigen on T cells.
50
￿
THE JOURNAL OF EXPERIMENTAL MEDICINE - VOLUME 142, 1975JUDITH A. KAPP, CARL W. PIERCE, AND BARUJ BENACERRAF
￿
51
cells from normal nonresponder mice incubated with GAT-MBSA (8; Kapp, unpublished
data). The suppressor cells are identified as T cells by their sensitivity to treatment with
anti-e serum and C and by the demonstration that suppressor cells are not retained by an
antimouse Ig column, but are eluted in the fraction containing 0-positive cells and a few
nonimmunoglobulin-bearing cells, but no immunoglobulin-bearing cells. In contrast, the
B cellseluted from thecolumn by normal mouse serum do nothave suppressor activity .
In their studies of the Ir gene-controlled responses to (T,G)-A--L, Hammerling and
McDevitt have observed (T,G)-A--L binding T cells in low responder, as well as high re-
sponder mice (9). In similar experiments, GAT-bindingT cells have been detected in non-
responder mice by Kennedy et al. I The observations that nonresponder mice have Tcells
capable of binding these antigens and that, in the case of the response to GAT, nonre-
sponder mice develop GAT-specific suppressor T cells suggest that the Ir genes may be-
have as regulatory genes rather than as genes coding for the antigen receptors on T cells.
It is critical to our understandingof the genetic control of immune responses to determine
whether nonresponder mice are restricted to the development of only suppressor T cells
after interaction with GAT, or whether conditions can be found which allow the develop-
ment of GAT-specific helper T cells in nonresponder mice.
We have found that GAT-specific helper T-cell function can develop in
nonresponder mice and in this communication we will describe the conditions for
eliciting and demonstrating GAT-specific helper T cells in nonresponder mice.
Materials and Methods
Mice.
￿
C57BL/6 (H-2°) and DBA/1 (H-2°) mice were purchased from the Jackson Laboratories,
Bar Harbor, Maine. The F, hybrid mice of (C57BL/6 x DBA/1) matings (H-2114) were produced in
our animal facilities. Mice used in these studies were 2- to 8-mo old and were maintained on
acidified-chlorinated drinking water and laboratory chow ad libitum.
Antigens. The synthetic linear random terpolymer GAT, mol wt 32,000 daltons, used in these
studies wassynthesized by Miles Laboratories, Kankakee, Ill. Preparation ofGAT, GAT-MBSA, and
GAT bound to peritoneal macrophages (GAT-M~P) for addition to cultures was described in detail
previously (4,6). 5 mg of soluble GAT, GAT-MBSA containing 5 ug GAT, or 7 x 10° macrophages
bearing 1-2ng of GAT were added to cultures according to the experimental protocol.
Immunization of Mice. Mice were injected intraperitoneally with 0.01 to 10.0 gg GAT,
GAT-MBSA containing 10 kg GAT, or 50 kg MBSA in a mixtureof magnesium-aluminum hydroxide
gel (Maalox, W.H. Rorer, Inc., Ft. Washington, Pa.) and pertussis vaccine (Eli Lilly, Indianapolis,
Ind.) as previously described (1). Other mice were injected intraperitoneally with 2 x 106 syngeneic
macrophages bearing 15-20 ng GAT.
Preparation of B Cells .
￿
8-bearingTcellswere eliminated from normal spleen cell suspensions by
treatment with AKR anti-B C3H serum and C before culture initiation (6). After treatment, 8 x 106
cells in MEM were addedto cultures with or without additional cells andwith GAT, GAT-MBSA, or
GAT-M~b according to the experimental protocol.
Preparation of T Cells. Since antigen-primed, helper T-cell function is radioresistant, mice
primed 1-4 mo earlier with GAT, GAT-MBSA, or GAT-MI) were X-irradiated with 700-800 R
delivered by aGeneral Electric Maximar250Type IIIX-Raytherapy unit (250 kvp, 15mA) (General
Electric, Medical Systems Div., Milwaukee, Wis.) as described previously (5,6,8). Within 3 h after
X-irradiation, the mice were sacrificed and single cell suspensions prepared from their spleens. 8 x
106 cells were added to cultures with or without additional cells and with antigen.
Spleen Cell Cultures and PFCAssay.
￿
Techniques of spleen cell culture andthehemolyticplaque
assay using GAT-SRBC as indicator cells have been described previously (4,6). The data in these
'Kennedy, L. J. Jr., M. E. Dorf, E. R. Unanue, and B. Benacerraf. Binding of poly
(Glue6Ala"Tyr'°) by thymic lymphocytes from genetic responder and nonresponder mice: effect of
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experiments are expressed as the geometric means of the number of GAT-specific IgG PFC per
culture from 3 to 13 separate experiments. To compare data from all experiments, the data from each
experiment were first normalized. Since each experiment contained cultures of normal spleen cells
stimulated by GAT-MBSA and since the purpose of each experiment was to assess the effect of
various populations of antigen-primed irradiated cells (T cells) on one population of normal spleen
cells treated with anti-B serum (B cells), we determined the geometric mean of the responses by 13
separate cultures of DBA/1 or F, spleen cells to GAT-MBSA (733 and594 GAT-specific IgGPFCper
culture, respectively) . The data in each experiment were then normalized as follows;
No. of PFC in spleen cell culture containing GAT-MBSA
x No. of PFC in experimental
733 or 574
group = normalized PFC/culture.
Results
Failure of Nonresponder (H-2Q) Mice to Develop GAT-Specific Helper T Cells
after Immunization with GAT. We have previously demonstrated that nonre-
sponder B10.S (H-2S) mice not only fail to develop a primary PFC response to
GAT, but also fail to develop radioresistant GAT-specific helper T-cell function
after injection with GAT (6). In contrast, (responder x nonresponder)F, (H-2°'s)
mice injected with GAT develop radioresistant GAT-specific helper T cells which
efficiently cooperate with F, B cells and responder (H-28) parental B cells in
responses to GAT, GAT-MBSA, and GAT-M-t . However, efficient cooperative
interaction with nonresponder (H-2s) parental B cells only occurs in cultures
stimulated with GAT-MBSA or GAT-M4), but not those stimulated with soluble
GAT (5) .
In the experiments reported here, nonresponder DBA/1 (H-2Q) and the
responder (C57BL/6 x DBA/1)F, (H-2'18) mice were compared for the presence
of radioresistant, GAT-specific helper T-cell function 1-4 mo after injection of
10 Ag GAT in Maalox-pertussis. The results (Fig. 1) verify that mice with an-
other nonresponder H-2 haplotype (H-24) fail to develop GAT-specific helper T
cells after injection of GAT. Groups A and B illustrate the GAT-specific IgG
PFC response by normal spleen cells from DBA/1 and (C57BL/6 x DBA/1)F,
incubated with GAT or GAT-MBSA. Control groups C, D, E, F, and J
demonstrate that normal B cells and antigen-primed, irradiated T cells fail to
develop GAT-specific PFC responses when cultured separately. Spleen cells from
DBA/1 mice primed with GAT 1-4 mo before X-irradiation and culture initiation
do not provide helper T-cell function for a response by DBA/1 B cells (group G) or
for F, B cells (group H) incubated with GAT or GAT-MBSA. The functional
capacity of F, B cells is verified by the observation that GAT-primed irradi-
ated F, T cells provided helper cell function for PFC responses to GAT and
GAT-MBSA (group I) . The failure of GAT-primed DBA/1 T cells to support a
response was not due to an unresponsive DBA/1 B-cell population; T cells from
GAT-MBSA-primed, irradiated DBA/1 mice when added to cultures of B cells,
the same as those in groups C and G, supported development of a GAT-specific
PFC response to GAT-MBSA. Significantly, data in Fig. 1 also demonstrate that
GAT-MBSA-primed DBA/1 T cells can cooperate with F, B cells in developing a
good response to GAT-MBSA and a much smaller but significant response to
GAT (group L). This response was observed in five out of eight experiments.
Although not shown, cultures of normal, irradiated DBA/1 spleen cells and F, BJUDITH A. KAPP, CARL W. PIERCE, AND BARUJ BENACERRAF
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FIG. 1.
￿
Failure of nonresponder DBA/1 mice (H-2°) to develop GAT-specific helper T cells
after immunization with GAT. GAT-specific IgG PFC response is expressed as the geometric
means of pooled normalized data. B cells were prepared by treating spleen cells from normal
DBA/1 or (C57BL/6 x DBA/1)F, mice with anti-B C3H serum plus C. T cells were obtained
from DBA/1or F, mice immunized 30 days or more before irradiation andculture initiation.
cells did not respond to GAT or GAT-MBSA. This experiment demonstrates that
GAT-specific helper T cells cannot be stimulated in nonresponder mice by GAT
using an immunization protocol which stimulates GAT-specific helper T cells in
responder animals. However, immunization with GAT-MBSA results in develop-
ment of weak but detectable GAT-specific T-cell helper activity, demonstrable,
however, only on F, B cells and not on nonresponder Bcells incubated with GAT.
It is important to note that the failure to detect GAT-specific helper T cells in
DBA/1 mice injected with GAT is not due to masking of helper activity by the
simultaneous presence of suppressor T cells because: (a) spleen cells were taken
from GAT-primed mice a month or more afterpriming at atime when suppressor
T cells can no longer be detected and the animals are again able to respond to
GAT-MBSA (Kapp, unpublished data); and (b) the spleen cells were taken from
X-irradiated mice and we have been unable to detect radioresistant suppressor
activity in this system.
Development of GAT-Specific Helper T Cells in DBA/1 Mice AfterImmuniza-
tion with GAT-MBSA or GAT-M(b.
￿
To further examine the antigen-specificity
C
D
B CELLS
NORMAL
DBA/I
Fl
T CELLS
GAT-PRIMED
-
-
- DBA/I
F - FI
G DBA/I DBA/I
// FI DBA/ I
Fl FI \\\\\\\MMOMMIMI\`
GAT-MBSA-PRIMED
,/ - DBA/I
K DBA/I DBA/I
L FI DBA/I54
￿
GENETIC CONTROL OF IMMUNE RESPONSES IN VITRO. VI
of helper T cells in GAT-MBSA primed DBA/1, and because of the known
suppressive activity of soluble GAT for nonresponder B cells, these T cells were
added to cultures of DBA/1 or F, B cells and incubated with macrophage-bound
GAT (Fig. 2) . Spleen cells from DBA/1 mice, like other nonresponder mice, did
not develop GAT-specific PFC responses when incubated with GAT bound to
syngeneic macrophages (5) . Furthermore, cultures containing GAT-MBSA-
primed DBA/1 T cells, DBA/1 B cells, and GAT bound to DBA/1 macrophages
(GAT-M~t) did not develop GAT-specific PFC responses (group A), whereas
these cells developed normal responses to GAT-MBSA. However, when GAT-
MBSA primed DBA/1 T cells were incubated with F, B cells and GAT-M4), a
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FIG. 2. Development of GAT-specific helper T cells in DBA/1 mice immunized with
GAT-MBSA, MBSA, or GAT-M~b. See Fig. 1 for (a) preparation of T and B cells and (b)
control PFC responses for cultures ofT andB cells incubated separately with antigen. Data for
responses to GATand GAT-MBSA in groups Aand B are the same as in Fig. 1, groups K and
L.
significant and highly reproducible GAT-specific response developed (group B) .
This demonstrated again that nonresponder mice immunized with GAT-MBSA
develop GAT-specific helper T cells . GAT-specific helper T cells can be
distinguished from MBSA-specific helper T cells because T cells from DBA/1
mice immunized with the carrier, MBSA, alone cooperate with F, B cells
incubated with GAT-MBSA, but not with GAT or GAT-M(P (group C) .
Since GAT itself does not stimulate the development of helper T cells in
DBA/1, two mechanisms could account for the development of GAT-specific
helper T cells in DBA/1 mice immunized with GAT-MBSA . The first is that
GAT must be bound to a carrier which is, itself, immunogeneic to stimulate the
development of GAT-specific helper T cells . Alternatively, GAT can stimulate
helper T cells in nonresponder mice if it is presented in a physical form which
does not elicit GAT-specific suppressor T cells .
To differentiate between these two alternatives, DBA/1 mice were injectedJUDITH A . KAPP, CARL W. PIERCE, AND BARUJ BENACERRAF
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with 2 to 4 x 106 peptone-induced DBA/1 peritoneal M4) bearing 15-20 ng of
GAT . After 5 wk, these mice were irradiated and examined for helper T-cell
activity specific for GAT. Cultures containing GAT-M4~-primed DBA/1 T cells
and DBA/1 B cells developed a GAT-specific response only when incubated with
GAT-MBSA, and not when incubated with soluble GAT or GAT-M4) (group D) .
The failure of these cultures to develop a response to soluble GAT can be
attributed to the sensitivity of nonresponder B cells to suppression by GAT in
vitro (7) . Since macrophage-bound GAT did not cause suppression of the
GAT-specific response to GAT-MBSA in vitro (5), another explanation must be
sought for the failure of GAT-specific DBA/1 helper T cells and DBA/1 B cells to
develop a response to GAT-M4~ compared to their ability to respond to
GAT-MBSA. One possibility is that the concentration of GAT on macrophages is
insufficient to stimulate nonresponder B cells. Alternatively, GAT-MBSA
overcomes a still to be defined defect in nonresponder B cells.
X-irradiated spleen cells from DBA/1 mice primed with GAT-M(b did
cooperate with F, B cells incubated with GAT-MBSA and GAT-M-t, but not
soluble GAT (group E) . Presently, we do not understand the variation in the
ability of GAT-specific DBA/1 T cells to support the F, B cell response to soluble
GAT (compare Fig . 1, group L and Fig . 2, group B to Fig. 2, group E) . It could,
however, be related to the differences in the immunization protocols used to
stimulate the GAT-specific helper T cells, i.e., immunization with GAT-MBSA
vs. GAT-M-t . Although the GAT-specific helper T-cell activity of primed,
irradiated DBA/1 spleen cells is more readily demonstrated in cultures contain-
ing responder B cells than in those containing nonresponder B cells, both sets of
data support the conclusion that GAT need not be bound to a carrier which is
itself immunogenic to stimulate GAT-specific helper T cells in nonresponder
mice .
Comparison of Suppressor and Helper T-Cell Activity in Mice Immunized with
Low Doses of GAT. We examined spleen cells from DBA/1 mice 7 days after
immunization with GAT-M(P (15-20 ng GAT) for the development of GAT-
specific PFC responses and found no detectable response . This finding correlated
with the failure of spleen cells from DBA/1 mice to respond to GAT-M4) in vitro,
but was inconsistent with the observation that DBA/1 mice immunized with
GAT-M-t develop radioresistant helper T cells. We therefore examined spleen
cells from mice primed 4 days earlier with GAT-Mt for the presence of
GAT-specific suppressor T cells . When co-cultured with spleen cells from normal
DBA/1 mice, these cells did not suppress the response of GAT-MBSA (Fig. 3,
group A). In fact, the response of cultures containing normal and GAT-M (b-
primed spleen cells was equal to the sum of the responses to the spleen cell
populations incubated separately. In contrast, mice immunized with 1 .0 to 10 Ag
GAT had developed suppressor T cells by 4 days after immunization (groups B
and C) . Spleen cells from mice immunized with less than 1 .0 hg GAT did not
suppress the response to GAT-MBSA of normal DBA/1 spleen cells (group D).
The amount of GAT (15-20 ng) which, when bound to macrophages,
stimulated the development of GAT-specific helper T cells (group A), was less
than the minimum (1 .0 gg) amount of GAT required to induce significant
suppressor T cells (group C) . In the event that the development of helper T cells56
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FIG. 3.
￿
Comparison of suppressor and helper T-cell activity in DBA/1 mice immunized with
low doses of GAT. Spleen cells from mice immunized 4 days earlier with GAT-M-t or GAT
were co-cultured with normal spleen cells and GAT-MBSA to detect suppressor cell activity .
The results (stipled bar) are expressed as the percentage of the response developed by normal
spleen cellsincubated with GAT-MBSA . Spleen cellsfrom primed mice were also examined 30
days after injection for the presence of GAT-specific helper T cells by co-culturing
antigen-primed irradiated spleen cells with normal B cells . These results (hatched bar) are
expressed as the percentage of the response developed by normal B cells and GAT-MBSA-
primed, irradiated Tcells incubated with GAT-MBSA .
in nonresponder mice requires only very low doses of GAT, we examined DBA/1
mice immunized with low doses of GAT for (a) development of GAT-specific PFC
responses in vivo and (b) presence of GAT-specific helper T cells after
immunization . Mice immunized with 10, 1 .0, 0.1, or 0.01 Ng GAT did not develop
a response to GAT in vivo (data not shown) nor did GAT-specific helper cells
arise which would cooperate with normal DBA/1 B cells incubated with
GAT-MBSA (groups B, C, D, E) .
We can conclude (a) that the failure of nonresponder mice to develop a
GAT-specific PFC response to GAT-M-~ is not due to a lack of helper T cells, nor
is it due to simultaneous stimulation of suppressor T cells ; and (b) mice
immunized with soluble GAT in doses too low to elicit suppressor T cells do not
develop helper T cells .
Discussion
The data presented in these studies demonstrate that GAT-specific helper T
cells can be elicited in nonresponder mice by administering GAT in the
appropriate form, i.e., GAT-MBSA or GAT-MD . However, this helper T-cell
activity generated in nonresponder mice immunized with GAT-MBSA or
GAT-M,t may be less effective than that generated in responder mice, since it is
incapable of providing helper T-cell function for nonresponder B cell, incubated
with GAT-MC However, these nonresponder B cells can be stimulated by
GAT-M4) in the presence of GAT-primed (responder x nonresponder)F 1 T cells
(5) . It is important to emphasize that GAT-specific helper T cells cannot be
identified in nonresponder mice by studying the GAT-specific antibody of intactJUDITH A. KAPP, CARL W. PIERCE, AND BARUJ BENACERRAF
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mice. In this circumstance, antibody is produced only when the mice are
immunized with GAT bound to a carrier such as MBSA or RBC, and the
influence of carrier-specific helper T cells obscures presence of GAT-specific
helper T cells.
Before discussing the relevance of these experiments to our understanding ofIr
gene-controlled antibody responses, we would like to summarize these findings
and those of earlier studies. (a) Injection of nonresponder mice with doses of
GAT (1-100 ug) in Maalox and pertussis which are immunogenic for responder
mice (i) fails to elicit a GAT-specific antibody response; (ii) elicits the develop-
ment of radiosensitive, GAT-specific suppressor T cells; and (iii) fails to elicit
radioresistant GAT-specific helper T cells. (b) Injection of nonresponder mice
with syngeneic macrophages bearing 15-20 ng of GAT (i) fails to elicit a GAT-
specific antibody response; (ii) fails to elicit GAT-specific suppressor T cells;
but (iii) stimulates the development of radioresistant GAT-specific helper T
cells. (c) Injection of nonresponder mice with GAT-MBSA in Maalox-pertussis
(i) stimulates the formation of GAT-specific antibody responses; and (ii) stimu-
lates the development of radioresistant helper T cells, but not detectable
suppressor T cells.
An interpretation of these observations is that theIr gene for GAT is expressed
in both B cells and T cells and that the process(es) controlled by this gene is very
sensitive to both the physical form and concentration of the antigen. Thus, with
regard to nonresponder T cells, soluble GAT preferentially stimulates suppressor
T-cell activity, whereas GAT bound to MBSA or to macrophages fails to
stimulate demonstrable suppressor T-cell activity, but does stimulate the
development ofGAT-specific helper Tcells. Withregard tononresponder B cells,
in contrast to responder B cells, soluble GAT has never elicited antibody
production in cultures of these B cells containing either DBA/1 or F, GAT-
specific helper T cells.
In contrast to the behavior of nonresponder mice, responder mice develop not
only GAT-specific antibody responses, but also develop radioresistant GAT-
specific helper T cells after stimulation with GAT, GAT-MBSA, and GAT-M4~.
It remains to be determined whether responder mice can develop GAT-specific
suppressor T cells.
From these observations, we must conclude that the difference between
responder and nonresponder mice is not in the absolute capacity to generate
GAT-specific helper T cells, nor in the capacity of B cells to produce GAT-
specific antibody. Based on the fact that both responder and nonresponder T
cells bind GAT and that both have the ability to develop into helper T cells, we
propose that some event occurs after antigen recognition which governs the de-
velopment of helper or suppressor T cells. Therefore, it is possible that, in the
case of the response to GAT, genetic control is not determined by the specificity
of antigen receptors on T cells, but is mediated by regulatory genes which func-
tion subsequent to antigen recognition. The possibility must be considered,
however, that the relatively complex antigens used to detect responses under
H-linked Ir gene control such as the terpolymer GAT may possess several deter-
minants capable ofstimulating T cells and that differentdeterminants stimulate
the development of suppressor vs. helper functions. This possibility is given58
￿
GENETIC CONTROL OF IMMUNE RESPONSES IN VITRO. VI
some support by the finding that the copolymer Of L-glutamic acid and L-alanine
(GA) is immunogenic in H-2g mice (10), whereas GAT with 10% tyrosine stimu-
lates the development of suppressor T cells in these mice. The suppressor T
cells in H-23 mice could therefore be specific for poly L-tyrosine sequence. This
possibility is currently being investigated.
Together with experiments of Mozes and collaborators (11-13) with the
branched copolymers, our studies on the process(es) controlled by Ir genes in the
GAT system indicate that the genetic defect can be expressed in T cells and B
cells or only in B cells. In their studies of the response to (T,G)-A--L, Mozes et
al., (11,12) found that thymocytes from low responder C3H/HeJ (H-2k) mice and
those from high responder C3H.SW (H-2b) mice educated to (T,G)-A--L produce
an antigen-specific factor capable of cooperating with responder (H-2°) but not
nonresponder (H-2'p) bone marrow cells in vivo. This suggests that the low
responder C3H/HeJ mice fail to produce high levels of antibody to (T,G)-A--L
because of a defect in the capacity of B cells to receive aT-cell signal rather than
a failure of their T cells to respond to (T,G)-A--L. In contrast, thymocytes from
the low responder SJL (H-2s) mice did not elaborate a (T,G)-A--L specific factor
nor did their B cells produce (T,G)-A--L-specific antibody when mixed with a
specific responder thymocyte factor, indicating a defect in both cell types (13) .
The H-linked Ir genes have only been demonstrated for antibody responses to
T-cell-dependent antigens and their action is concerned either with the genera-
tion of helper or suppressor T-cell function, or with the effectiveness of helper
T-cell function for B cells. It is therefore reasonable to consider that the
process(es) controlled by these genes is concerned with T cell-T cell and/or T
cell-B-cell interactions in the regulation of immune responses. Further, it is not
unexpected that the genes concerned with the control of these crucial interac-
tions have been mapped in the Iregion of the H-2 complex in precisely the same
region where H-linked Ir genes are located (14), and that the murine immune
responses to T-cell-dependent antigens can be inhibited in vitro by the addition
of alloantisera directed against the K and I regions of the H-2 gene complex (15,
footnote 3). The recent discovery that factors from activated T cells with helper
or suppressor activity are both antigen-specific (16,17) and may possess deter-
minants coded for in the H-2 complex (16) is consistent with this interpretation.
Summary
Mice which are genetic nonresponders to the random terpolymer of L-glutamic
acids°-L-alanine"-L-tyrosine" (GAT) not only fail to develop GAT-specific anti-
body responses when stimulated with soluble GAT either in vivo or in vitro, but
develop GAT-specific T cells which suppress the GAT-specific plaque-forming
cell response of normal nonresponder mice stimulated with GAT complexed to
methylated bovine serum albumin (MBSA) . Thus, both responder and nonre-
sponder mice have T cells which recognize GAT. However, nonresponder mice
can develop GAT-specific helper T cells if immunized with GAT bound to
'Pierce, C. W. Manuscript in preparation.JUDITH A. KAPP, CARL W. PIERCE, AND BARUJ BENACERRAF
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MBSA or to macrophages. The relevance of Ir gene-controlled responses is dis-
cussed.
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